“We project that vaccines are probably going to peak early in the fourth quarter before declining in 2024, and that's primarily due to COVID softening versus part of the early part of '23 when the public health emergency was still in effect.”

In context

“to ramp and some of the benefits that you're starting to see from that particularly as we've exceeded all of our goals on employee retention, but importantly, on script retention and also front store retention. So we've done really well and kudos to that team on the execution there. But as you think maybe about the immunization franchise, we did just under 8 million vaccines in the quarter. Flu represented probably about half of that total with COVID probably about a quarter, and the remainder is a variety of different vaccines, but also included the new RSV vaccine, which we saw a strong growth in. Performance across that book was quite good, and a lot of that actually has to do with some of the efforts of our trade team, which helped to really drive some of the strength in the quarter. We project that vaccines are probably going to peak early in the fourth quarter before declining in 2024, and that's primarily due to COVID softening versus part of the early part of '23 when the public health emergency was still in effect. As COVID moves into the endemic phase, our plan is that we're going to talk about the vaccine franchise more holistically and but we do think that there's going to be pressure there because COVID is going to wane. And I think as you think about next year, we've anticipated that the current level of performance is not going to persist partially because of COVID, partially because of the typical dynamics of just rate and reimbursement pressure but also about a little bit of a provision for consumer softness. Prem, maybe you could talk a little bit about -- more about kind of the script growth and underlying dynamics in the market. Prem Shah: Yeah, sure. Sure. Thanks. So our retail pharmacy business continues to be execute and deliver strong results across scripts service and our transformat”